Related Experiment Video
Updated: Jul 18, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Dietary fat, genes and insulin sensitivity
José López-Miranda1, Pablo Pérez-Martínez, Carmen Marin
1Lipid and Arteriosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Avda Menéndez Pidal, s/n, 14004, Cordova, Spain. md1lomij@uco.es
Journal of Molecular Medicine (Berlin, Germany)
|December 16, 2006
Summary
Genetic factors and diet interact to influence insulin resistance and dyslipidemia. Personalized nutrition may be key for managing these conditions due to complex gene-environment interactions.
Area of Science:
- Metabolic Syndrome Research
- Nutrigenetics and Nutrigenomics
Background:
- Insulin resistance and dyslipidemia are influenced by both genetic and environmental factors.
- Gene variants can impact insulin signaling and lipid metabolism.
- Genetic susceptibility plays a significant role in the insulin resistance syndrome.
Purpose of the Study:
- To review recent studies on gene variants affecting insulin signaling.
- To examine gene-diet interactions predisposing individuals to insulin resistance.
- To highlight the role of genetic background in metabolic syndrome development.
Main Methods:
- Review of recent scientific literature.
- Analysis of gene variants impacting insulin action and dyslipidemia.
- Examination of gene-environment interactions, specifically diet.
Main Results:
- Recent findings underscore the importance of genetic susceptibility to insulin resistance syndrome.
- Nutrition, particularly dietary fat composition, interacts with genetic background.
- Gene variants and their environmental interactions are key modulators of glucose metabolism.
Conclusions:
- Complex gene-environment interactions necessitate a personalized nutrition approach for future therapies.
- Understanding genetic predispositions and dietary influences is crucial for managing insulin resistance and dyslipidemia.
- Gene variants significantly modulate glucose metabolism and the insulin resistance syndrome.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...